Arcus Biosciences, Inc. (RCUS) on GreekSoup https://greeksoup.ai/stocks/us/rcus/ Every dated entry in the public record on Arcus Biosciences, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Mon, 12 Oct 2026 00:00:00 +0000 Arcus Biosciences, Inc.: short interest 13,110,576 shares at the 30 September 2026 settlement, 7.64 days to coverhttps://greeksoup.ai/stocks/us/rcus/short-interest/us:RCUS:short-interest:2026-09-30:30609ce74bWed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Arcus Biosciences, Inc.: short interest 13,812,606 shares at the 15 September 2026 settlement, 7.81 days to coverhttps://greeksoup.ai/stocks/us/rcus/short-interest/us:RCUS:short-interest:2026-09-15:eb3f7b7d68Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Arcus Biosciences, Inc.: short interest 13,076,244 shares at the 31 August 2026 settlement, 10.96 days to coverhttps://greeksoup.ai/stocks/us/rcus/short-interest/us:RCUS:short-interest:2026-08-31:4a6496b3e3Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Arcus Biosciences, Inc.: Azoy Alexander (Chief Accounting Officer) sold 2,827 shares at $30.00 on 21 August 2026, $84,810https://greeksoup.ai/stocks/us/rcus/insiders/us:RCUS:insider:2026-08-24:10d8d2f09cMon, 24 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Arcus Biosciences, Inc.: Form 144, ALEXANDER AZOY plans to sell 2,827 shares worth $83,453 around 21 August 2026https://greeksoup.ai/stocks/us/rcus/planned-sales/us:RCUS:planned-sale:2026-08-21:2bca0649a2Fri, 21 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Arcus Biosciences, Inc.: short interest 13,848,822 shares at the 14 August 2026 settlement, 12.30 days to coverhttps://greeksoup.ai/stocks/us/rcus/short-interest/us:RCUS:short-interest:2026-08-14:90ee0da8e8Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Arcus Biosciences, Inc. Q2 FY2026 results: revenue $41 million, net income -$91 millionhttps://greeksoup.ai/stocks/us/rcus/results/fy2026-q2/us:RCUS:result:2026-08-05:1a5b5dafdbWed, 05 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Arcus Biosciences, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/rcus/filings/us:RCUS:filing:2026-08-05:35400227c3Wed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Arcus Biosciences, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/rcus/filings/us:RCUS:filing:2026-08-05:520f00db57Wed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Arcus Biosciences, Inc.: short interest 13,118,220 shares at the 31 July 2026 settlement, 11.60 days to coverhttps://greeksoup.ai/stocks/us/rcus/short-interest/us:RCUS:short-interest:2026-07-31:517ca8cb01Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Arcus Biosciences, Inc.: short interest 12,559,230 shares at the 15 July 2026 settlement, 12.92 days to coverhttps://greeksoup.ai/stocks/us/rcus/short-interest/us:RCUS:short-interest:2026-07-15:c7aacf0126Wed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>